Repare Therapeutics Files 8-K on Shareholder Votes
| Field | Detail |
|---|---|
| Company | Repare Therapeutics Inc. |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Repare Therapeutics held a shareholder vote on June 17, 2025. Details TBD.
AI Summary
Repare Therapeutics Inc. filed an 8-K on June 17, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or resolutions presented, but it formally documents that such matters were addressed.
Why It Matters
This filing indicates that Repare Therapeutics held a shareholder meeting or took action requiring a vote, which is a standard corporate governance event.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure about shareholder votes and does not contain new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- Repare Therapeutics Inc. (company) — Registrant
- June 17, 2025 (date) — Date of earliest event reported
FAQ
What specific matters were submitted to a vote of Repare Therapeutics' security holders on June 17, 2025?
The 8-K filing does not specify the exact matters voted upon, only that such matters were submitted.
What were the results of the votes mentioned in the filing?
The filing does not disclose the results of any votes taken.
Was this a special meeting or an annual meeting of shareholders?
The filing does not specify whether the vote was part of an annual or special meeting.
Does this 8-K filing contain any financial updates for Repare Therapeutics?
No, this 8-K filing is specifically for reporting matters submitted to a vote of security holders and does not contain financial updates.
Where is Repare Therapeutics Inc. headquartered?
Repare Therapeutics Inc. is headquartered in Saint-Laurent, Québec, Canada.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding Repare Therapeutics Inc..